-
-
-
-
-
-
-
Sarepta Therapeutics (SRPT) option implied volatility into PDUFA
-
-
-
-
-
-
-
Sarepta Therapeutics (SRPT) calls more active than puts into PDUFA
-
-
-
-
-
-
-
Sarepta Therapeutics Announces Positive Vote from U.S. FDA Advisory Committee Meeting for SRP-9001 Gene Therapy to Treat Duchenne Muscular Dystrophy
-
-
-
-
-
-
-
Sarepta Therapeutics (SRPT) Tops Q2 EPS by 54c
-
-
-
-
-
-
-
After-Hours Stock Movers 02/28: (DVAX) (BGFV) (DAR) Higher; (PANW) (SRPT) (ENPH) Lower (more...)
-
-
-
-
-
-
-
Sarepta Therapeutics (SRPT): Termination of BioMarin's DMD Programs Increases Future Value - Wedbush
-
-
-
-
-
-
-
Sarepta (SPRT) volatility elevated into FDA extends review of eteplirsen
-
12,336 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All